ID   Mero-41
AC   CVCL_2592
SY   MERO41
DR   cancercelllines; CVCL_2592
DR   Cell_Model_Passport; SIDM01903
DR   DepMap; ACH-001557
DR   ECACC; 09100103
DR   Wikidata; Q54905206
RX   PubMed=2474517;
RX   PubMed=2790740;
RX   PubMed=25902174;
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Transformant: ChEBI; CHEBI_46661; Asbestos.
CC   Omics: Deep exome analysis.
CC   Derived from site: In situ; Pleural effusion; UBERON=UBERON_0000175.
ST   Source(s): DepMap=ACH-001557; ECACC=09100103
ST   Amelogenin: X,Y
ST   CSF1PO: 10,11
ST   D13S317: 13
ST   D16S539: 12
ST   D18S51: 14
ST   D21S11: 30,31.2
ST   D3S1358: 16
ST   D5S818: 13
ST   D7S820: 9
ST   D8S1179: 12,14
ST   FGA: 22
ST   Penta D: 9,11
ST   Penta E: 7,15
ST   TH01: 6,8
ST   TPOX: 8
ST   vWA: 17
DI   NCIt; C45662; Pleural epithelioid mesothelioma
DI   ORDO; Orphanet_50251; Pleural mesothelioma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   >60Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 19-12-24; Version: 20
//
RX   PubMed=2474517; DOI=10.1002/ijc.2910440212;
RA   Versnel M.A., Bouts M.J., Hoogsteden H.C., van der Kwast T.H.,
RA   Delahaye M., Hagemeijer A.;
RT   "Establishment of human malignant mesothelioma cell lines.";
RL   Int. J. Cancer 44:256-260(1989).
//
RX   PubMed=2790740; DOI=10.1016/0165-4608(89)90014-9;
RA   Versnel M.A., Hoogsteden H.C., Hagemeijer A., Bouts M.J.,
RA   van der Kwast T.H., Delahaye M., Schaart G., Ramaekers F.C.S.;
RT   "Characterization of three human malignant mesothelioma cell lines.";
RL   Cancer Genet. Cytogenet. 42:115-128(1989).
//
RX   PubMed=25902174; DOI=10.1097/JTO.0000000000000493;
RA   Miyanaga A., Masuda M., Tsuta K., Kawasaki K., Nakamura Y., Sakuma T.,
RA   Asamura H., Gemma A., Yamada T.;
RT   "Hippo pathway gene mutations in malignant mesothelioma: revealed by
RT   RNA and targeted exon sequencing.";
RL   J. Thorac. Oncol. 10:844-851(2015).
//